Home Healthcare Biotechnology Live Attenuated Vaccines Market

Live Attenuated Vaccines Market Size, Share & Trends Analysis Report By Product (Viral, Bacterial), By Disease Indication (Measles, Mumps, and Rubella (MMR), Varicella (Chickenpox), Influenza, Rotavirus, Yellow Fever, Polio, Others), By Route of Administration (Oral, Parenteral, Intranasal), By Age Group (Pediatric, Adult) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Live Attenuated Vaccines Market Size Analysis
    1. Introduction
    2. Live Attenuated Vaccines Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Viral
      2. Bacterial
    3. Live Attenuated Vaccines Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Measles, Mumps, and Rubella (MMR)
      2. Varicella (Chickenpox)
      3. Influenza
      4. Rotavirus
      5. Yellow Fever
      6. Polio
      7. Others
    4. Live Attenuated Vaccines Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
      3. Intranasal
    5. Live Attenuated Vaccines Market Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
      1. Pediatric
      2. Adult
  7. North America Live Attenuated Vaccines Market Size Analysis
    1. Introduction
    2. Live Attenuated Vaccines Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Viral
      2. Bacterial
    3. Live Attenuated Vaccines Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Measles, Mumps, and Rubella (MMR)
      2. Varicella (Chickenpox)
      3. Influenza
      4. Rotavirus
      5. Yellow Fever
      6. Polio
      7. Others
    4. Live Attenuated Vaccines Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
      3. Intranasal
    5. Live Attenuated Vaccines Market Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
      1. Pediatric
      2. Adult
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
  8. Europe Live Attenuated Vaccines Market Size Analysis
    1. Introduction
    2. Live Attenuated Vaccines Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Viral
      2. Bacterial
    3. Live Attenuated Vaccines Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Measles, Mumps, and Rubella (MMR)
      2. Varicella (Chickenpox)
      3. Influenza
      4. Rotavirus
      5. Yellow Fever
      6. Polio
      7. Others
    4. Live Attenuated Vaccines Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
      3. Intranasal
    5. Live Attenuated Vaccines Market Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
      1. Pediatric
      2. Adult
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    8. France
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
  9. APAC Live Attenuated Vaccines Market Size Analysis
    1. Introduction
    2. Live Attenuated Vaccines Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Viral
      2. Bacterial
    3. Live Attenuated Vaccines Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Measles, Mumps, and Rubella (MMR)
      2. Varicella (Chickenpox)
      3. Influenza
      4. Rotavirus
      5. Yellow Fever
      6. Polio
      7. Others
    4. Live Attenuated Vaccines Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
      3. Intranasal
    5. Live Attenuated Vaccines Market Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
      1. Pediatric
      2. Adult
    6. China
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    9. India
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    11. Singapore
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    12. Taiwan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    13. South East Asia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    14. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
  10. Middle East and Africa Live Attenuated Vaccines Market Size Analysis
    1. Introduction
    2. Live Attenuated Vaccines Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Viral
      2. Bacterial
    3. Live Attenuated Vaccines Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Measles, Mumps, and Rubella (MMR)
      2. Varicella (Chickenpox)
      3. Influenza
      4. Rotavirus
      5. Yellow Fever
      6. Polio
      7. Others
    4. Live Attenuated Vaccines Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
      3. Intranasal
    5. Live Attenuated Vaccines Market Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
      1. Pediatric
      2. Adult
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
  11. LATAM Live Attenuated Vaccines Market Size Analysis
    1. Introduction
    2. Live Attenuated Vaccines Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Viral
      2. Bacterial
    3. Live Attenuated Vaccines Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Measles, Mumps, and Rubella (MMR)
      2. Varicella (Chickenpox)
      3. Influenza
      4. Rotavirus
      5. Yellow Fever
      6. Polio
      7. Others
    4. Live Attenuated Vaccines Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
      3. Intranasal
    5. Live Attenuated Vaccines Market Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
      1. Pediatric
      2. Adult
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Viral
        2. Bacterial
      3. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Measles, Mumps, and Rubella (MMR)
        2. Varicella (Chickenpox)
        3. Influenza
        4. Rotavirus
        5. Yellow Fever
        6. Polio
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Intranasal
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
  12. Competitive Landscape
    1. Live Attenuated Vaccines Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Merck & Co., Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. GlaxoSmithKline plc (GSK)
    3. Sanofi
    4. Pfizer Inc.
    5. AstraZeneca plc
    6. Serum Institute of India Pvt. Ltd.
    7. Bharat Biotech
    8. Emergent BioSolutions Inc.
    9. Bavarian Nordic
    10. Takeda Pharmaceutical Company Limited 
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer

List of Tables

Table 1: Global Live Attenuated Vaccines Market Size and Forecast By Regions - 2022-2034 (USD Billion)

Table 2: Global Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 3: Global Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 4: Global Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 5: Global Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 6: North America Live Attenuated Vaccines Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 7: North America Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 8: North America Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 9: North America Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 10: North America Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 11: U.S. Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 12: U.S. Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 13: U.S. Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 14: U.S. Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 15: Canada Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 16: Canada Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 17: Canada Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 18: Canada Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 19: Europe Live Attenuated Vaccines Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 20: Europe Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 21: Europe Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 22: Europe Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 23: Europe Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 24: U.K. Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 25: U.K. Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 26: U.K. Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 27: U.K. Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 28: Germany Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 29: Germany Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 30: Germany Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 31: Germany Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 32: France Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 33: France Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 34: France Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 35: France Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 36: Spain Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 37: Spain Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 38: Spain Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 39: Spain Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 40: Italy Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 41: Italy Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 42: Italy Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 43: Italy Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 44: Russia Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 45: Russia Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 46: Russia Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 47: Russia Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 48: Nordic Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 49: Nordic Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 50: Nordic Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 51: Nordic Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 52: Benelux Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 53: Benelux Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 54: Benelux Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 55: Benelux Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 56: Rest of Europe Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 57: Rest of Europe Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 58: Rest of Europe Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 59: Rest of Europe Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 60: APAC Live Attenuated Vaccines Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 61: APAC Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 62: APAC Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 63: APAC Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 64: APAC Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 65: China Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 66: China Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 67: China Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 68: China Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 69: Korea Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 70: Korea Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 71: Korea Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 72: Korea Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 73: Japan Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 74: Japan Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 75: Japan Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 76: Japan Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 77: India Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 78: India Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 79: India Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 80: India Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 81: Australia Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 82: Australia Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 83: Australia Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 84: Australia Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 85: Singapore Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 86: Singapore Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 87: Singapore Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 88: Singapore Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 89: Taiwan Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 90: Taiwan Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 91: Taiwan Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 92: Taiwan Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 93: South East Asia Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 94: South East Asia Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 95: South East Asia Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 96: South East Asia Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 97: Rest of Asia-Pacific Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 98: Rest of Asia-Pacific Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 99: Rest of Asia-Pacific Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 100: Rest of Asia-Pacific Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 101: Middle East and Africa Live Attenuated Vaccines Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 102: Middle East and Africa Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 103: Middle East and Africa Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 104: Middle East and Africa Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 105: Middle East and Africa Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 106: UAE Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 107: UAE Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 108: UAE Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 109: UAE Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 110: Turkey Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 111: Turkey Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 112: Turkey Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 113: Turkey Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 114: Saudi Arabia Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 115: Saudi Arabia Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 116: Saudi Arabia Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 117: Saudi Arabia Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 118: South Africa Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 119: South Africa Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 120: South Africa Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 121: South Africa Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 122: Egypt Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 123: Egypt Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 124: Egypt Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 125: Egypt Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 126: Nigeria Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 127: Nigeria Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 128: Nigeria Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 129: Nigeria Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 130: Rest of MEA Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 131: Rest of MEA Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 132: Rest of MEA Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 133: Rest of MEA Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 134: LATAM Live Attenuated Vaccines Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 135: LATAM Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 136: LATAM Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 137: LATAM Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 138: LATAM Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 139: Brazil Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 140: Brazil Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 141: Brazil Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 142: Brazil Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 143: Mexico Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 144: Mexico Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 145: Mexico Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 146: Mexico Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 147: Argentina Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 148: Argentina Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 149: Argentina Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 150: Argentina Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 151: Chile Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 152: Chile Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 153: Chile Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 154: Chile Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 155: Colombia Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 156: Colombia Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 157: Colombia Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 158: Colombia Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 159: Rest of LATAM Live Attenuated Vaccines Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 160: Rest of LATAM Live Attenuated Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 161: Rest of LATAM Live Attenuated Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 162: Rest of LATAM Live Attenuated Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.